Martin A. Lehr - 09 Jun 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Executive Officer, Director
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 09 Jun 2025
Net transactions value: +$70,080
Form type: 4
Filing time: 10 Jun 2025, 17:26:21 UTC
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lehr Martin A.	Chief Executive Officer, Director	2001 MARKET STREET, SUITE 3915, UNIT #15, PHILADELPHIA	/s/ Alex Levit, Attorney-in-Fact	10 Jun 2025	0001861989

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTX	Common Stock	Purchase	$70,080	+100,000	+12%	$0.7008	920,190	09 Jun 2025	Martin Lehr 2000 Trust	F1
holding	CNTX	Common Stock						159,701	09 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Content

The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.